Improving intraperitoneal chemotherapeutic effect and preventing postsurgical adhesions simultaneously with...

Area of Science:

• Biomedical Engineering
• Oncology
• Drug Delivery Systems

Background:

• Cytoreductive surgery for abdominal/pelvic malignancies frequently results in residual tumors and peritoneal adhesions, negatively impacting patient prognosis.
• Current treatments struggle to simultaneously address both residual disease and postsurgical adhesions effectively.

Purpose of the Study:

• To develop and evaluate a novel strategy combining a controlled drug delivery system (CDDS) with an antiadhesion barrier.
• To improve intraperitoneal chemotherapeutic efficacy and prevent postsurgical adhesions concurrently.

Main Methods:

• Development of biodegradable poly(ethylene glycol)-poly(ɛ-caprolactone)-poly(ethylene glycol) (PECE) copolymer micelles (Dox-M) for doxorubicin delivery.
• Formation of a temperature-sensitive gel from PECE micelles at body temperature.
• Establishment of a mouse model for postsurgical residual tumors and peritoneal adhesions.

Main Results:

• Dox-M demonstrated effectiveness in enhancing intraperitoneal chemotherapy.
• The PECE-based system successfully prevented postsurgical peritoneal adhesions.
• The combined strategy showed simultaneous improvement in chemotherapeutic effect and adhesion prevention in the established mouse model.

Conclusions:

• Combining a CDDS with an antiadhesion barrier presents a promising strategy for postsurgical management of abdominal and pelvic malignancies.
• This dual-action approach offers a potential solution to improve outcomes by simultaneously tackling residual tumors and preventing adhesions.